CVS HEALTH CORPORATION vs. NVIDIA Corporation
CVS HEALTH CORPORATION and NVIDIA Corporation are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| CVS | NVDA | |
|---|---|---|
| Market Cap | $113.99 billion | $5.43 trillion |
| Revenue (TTM) | — | $302.97 billion |
| Net Income (TTM) | — | $192.88 billion |
NVDA leads on 1 of 1 size & scale factors.
Valuation
| CVS | NVDA | |
|---|---|---|
| P/E Ratio | — | 28.45 |
| Price / Book | 1.43 | 23.73 |
| Price / Sales | — | 17.94 |
CVS leads on 1 of 1 valuation factors.
Profitability
| CVS | NVDA | |
|---|---|---|
| Net Margin | — | 63.66% |
| Return on Equity | — | 84.23% |
CVS and NVDA split the profitability factors evenly.
Dividend
| CVS | NVDA | |
|---|---|---|
| Dividend Yield | 2.98% | 0.44% |
| Payout Ratio | — | 12.64 |
CVS leads on 1 of 1 dividend factors.
Risk & Sentiment
| CVS | NVDA | |
|---|---|---|
| Short Interest | 2.58% | 0.07% |
NVDA leads on 1 of 1 risk & sentiment factors.
Dig deeper: CVS overview, CVS financials, NVDA overview, NVDA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.